uniQure N.V.'s revenue has shrunk 45% a year over three years, and shrunk 48% a year over five. Revenue growth, 3-year annual rate: −45% (Biotechnology median +21%). Revenue growth, 5-year rate: −48%, growth has picked up over the last three years. Years of annual history on file: 12, FY2014 to FY2025, as filed.

QUREuniQure N.V.

Healthcare

$22.41-63% 1Y

$22.41

$9.0352 weeks$70.59

Is it growing?

Good

Growing: revenue growing +30% year on year and operating margin widening (+376.5 points).

2 good, 1 without data

Revenue trend+30% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: −48% a year.

Margin direction+376.5 points operating

Trailing-twelve-month operating margin, -1118.6% now against -1495.1% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is QURE growing?

uniQure N.V.'s revenue has shrunk 45% a year over three years, and shrunk 48% a year over five.

−45%

Revenue growth, 3-year annual rate · Biotechnology median +21% · shrinking · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: −48%
Revenue growth, 5-year rate · −45% over three · growth has picked up over the last three years
Years of annual history on file: 12
Years of annual history on file · FY2014 to FY2025, as filed

Details›